1 September 2024

Starpharma Investor Presentation for Citi Conference

Melbourne, Australia; 17 October 2018: Starpharma (ASX: SPL, OTCQX: SPHRY) will today participate in Citi's 10th Annual Australian and New Zealand Investment Conference in Sydney.

The invitation-only Citi Conference brings together 65 ASX listed companies with over 700 investors and fund managers.

During the event Starpharma’s Chief Executive Officer, Dr Jackie Fairley, will be presenting the attached slides in meetings with a number of new and existing institutional investors. A copy of the presentation being provided is attached and available on the Starpharma website at www.starpharma.com.

Download ASX Announcement: Starpharma Investor Presentation for Citi Conference (PDF, 2.9MB)

 

 

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.